Venous Disease and Leg Ulcers. Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL

Similar documents
Conflict of Interest. None

Why Tumescent-Free Therapy Will Replace RF and Laser

Epidemiology: Prevalence

Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA

Vein Disease Treatment

New Guideline in venous ulcer treatment: dressing, medication, intervention

How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN.

Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015

2017 Florida Vascular Society

Chronic Venous Insufficiency Compression and Beyond

Non-Saphenous Vein Treatments. Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO

6/1/2017. Mechanico-Chemical Ablation MOCA? Disclaimer

Endovenous Thermal vs. Endovenous Chemical Ablation What is the Best for the Patient

Treatment of Varicose Veins

Clinical case. Symptomatic anterior accessory great saphenous vein (AAGSV) reflux

Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden

RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY

Current Management of Varicose Veins

Techniques and Specific Treatment Modalities for the Active Non-Healing Wound. Luke Maj, MD, MHA

Patient assessment and strategy making for endovenous treatment

o Self-Contained & Disposable: Fully self-contained, single-use device with no need for capital equipment purchase

Criteria For Medicare Members. Kaiser Foundation Health Plan of Washington

LINC, Christine Teichert, MD University Medicine of Rostock, Dept. of diagnostic and interventional radiology, Germany

Thermal Techniques: Outcomes and Complications

Clinical/Duplex Evaluation of Varicose Veins: Who to Treat?

Medical Policy. Description/Scope. Position Statement

RE: Request for coverage and reimbursement for mechano-chemical venous ablation Clarivein

Additional Information S-55

MOCA and GLUE: results and analyses of the RCTs

Endo-Thermal Heat Induced Thrombosis (E-HIT)

New Technologies in Superficial Vein Treatment

Mindful Reflections On The Management. of Venous Ulceration. Presenter name. Title Date

Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue)

Medicare C/D Medical Coverage Policy

MEDICAL POLICY SUBJECT: VARICOSITIES, TREATMENT ALTERNATIVES TO VEIN STRIPPING AND LIGATION

Recurrent Varicose Veins We All See Them

MEDICAL POLICY SUBJECT: VARICOSITIES, TREATMENT ALTERNATIVES TO VEIN STRIPPING AND LIGATION. POLICY NUMBER: CATEGORY: Technology Assessment

Management of Side Branches and Perforating Veins

Treatment of Varicose Veins/Venous Insufficiency

MEDICAL POLICY SUBJECT: VARICOSITIES, TREATMENT ALTERNATIVES TO VEIN STRIPPING AND LIGATION

Selection and work up for the right patients suspected of deep venous disease

Page 1. Ruling out deep venous obstruction prior to superficial vein treatment. Disclosures. Indications for saphenous vein ablation (SVA)

Disclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach.

Understanding venous disease and treatment options for your patients. Christopher Wulff, MD

Which place for liquid sclerotherapy? Eberhard Rabe Department of Dermatology University of Bonn Germany

Treatment of Varicose Veins/Venous Insufficiency. Description

Medical Affairs Policy

AMERICAN PODIATRIC MEDICAL ASSOCIATION

Le varici recidive Recurrent varices: how to manage them?

A treatment option for varicose veins. enefit" Targeted Endovenous Therapy. Formerly known as the VNUS Closure procedure E 3 COVIDIEN

Corporate Medical Policy

SAFETY AND FEASIBILITY OF MECHANO-CHEMICAL ABLATION OF VARICOSE VEINS: INITIAL RESULTS

RADIOFREQUENCY ABLATION. Drs PIRET V, BERGERON P MEET CANNES 2009

Chronic Venous Insufficiency

Non-compressive sclerotherapy is not covered by Medicare because it is not effective in producing long-term obliteration of incompetent veins.

TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY

Endothermal Ablation for Venous Insufficiency. Dr. S. Kundu Medical Director The Vein Institute of Toronto

Mechanochemical endovenous ablation in the treatment of varicose veins van Eekeren, Ramon

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

Step by step ultrasound examination of varicose veins. Dr. Özgün Sensebat Vascular Surgeon Private Vascular Clinic Dorsten & Borken, Germany

Treatment of Varicose Veins/Venous Insufficiency

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

ABLATIVE AND SURGICAL TREATMENT FOR VENOUS INSUFFICIENCY

ClariVein Õ Early results from a large single-centre series of mechanochemical endovenous ablation for varicose veins

Patients with varicose veins (VV)

MEDICAL POLICY SUBJECT: VARICOSITIES, TREATMENT ALTERNATIVES TO VEIN STRIPPING AND LIGATION

Subject: Treatments for Varicose Veins/Venous Insufficiency

WHAT ABOUT FOAM SCLEROTHERAPY IN REVAS? Dr O CRETON Ste FOY LES LYON

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

UNDERSTANDING VEIN DISEASE. UC EN - For use in the U.S. only

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency. A Prospective, Multi-centre Study

Treatment of Varicose Veins/Venous Insufficiency

The role of ultrasound duplex in endovenous procedures

Treatment of Varicose Veins/Venous Insufficiency Corporate Medical Policy

Complex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.

What can we learn from randomized trials comparing endovenous and open surgery for primary varicosis? an overview Prof. Dr. Thomas M.

Abstracts Vaeshartelt 14 mei 2011 Résumés Vaeshartelt mai 2011

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

FIND RELIEF FROM VARICOSE VEINS. VenaSeal Sapheon Closure System

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:

FIND RELIEF FROM VARICOSE VEINS. VenaSeal Closure System

FEP Medical Policy Manual

Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results

N.S. Theivacumar, R.J. Darwood, M.J. Gough*

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Venous Ulcers. A Little Basic Science. An Aggressive Prescription to Aid Healing. Why do venous ulcers occur? Ambulatory venous hypertension!

Varithena 3 rd February 2015

SAVE LIMBS SAVE LIVES! Endovenous Ablation for Chronic Wounds

Sadie Ahanchi, MD Sentara Vascular Specialists April 27,2018. Debate 1: Why Is Tumescent-Based Therapy The Gold Standard?

VARICOSE VEINS AND VENOUS INSUFFICIENCY

PROVIDER POLICIES & PROCEDURES

COMMISSIONING POLICY

Find From Varicose Veins. VenaSeal

Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous vein

Varicose veins. Natural history, assessment and management. Arteries and veins. Why do people get varicose veins? Classification of venous disease

Transcription:

Venous Disease and Leg Ulcers Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL

Disclosures Stocks Endoshape Sapheon Medical Advisory Board BTG, Boston Scientific

Venous Leg Ulcer Most common leg ulcer Mostly due to superficial disease or combination of superficial and deep Rarely a cause of leg loss but a cause of significant disability Many options for treatment that lessen recurrence and possibly speed healing almost all office base and the remaining mostly outpatient

Venous Ulcer Pathophysiology Venous stasis Fig 3 Capillary distension Fig 1 Fibrin deposition in dermis; fibrinous pericapillary cuff forms Skin deprived of oxygen and nutrients Fig 2 Skin destruction Fig 1: Phua J. http://podiatry.curtin.edu.au/encyclopedia/venous_leg_ulcer/legulcer.html Fig 2: Image courtesy of David MacMillan, MD Fig 3: Adapted from Paletta C, Massey B. Vascular Ulcers. http://www.emedicine.com/plastic/topic467.htm. 2005

Causes of Stasis or Venous Hypertension Reflux or valve failure: -superficial axial Great, Small, Accessory Saphenous veins -perforator -pelvic -deep Obstruction Iliac, femoral and popliteal Pump failure

Diagnosis of Reflux History and Physical Duplex mapping

Treatment Options for Superficial Axial Reflux Compression Traditional surgery: ligation, stripping Endovenous Thermal Ablation Mechanical Chemical Ablation Chemical Ablation

Action of GC Hose

Endovenous Thermal Ablation RF Closure now Venefit Endovenous Laser of which multiple suppliers Requires Tumescent anesthesia Requires fairly straight vein Cannot treat right under the skin

ULTRSOUND GUIDED VENOPUNCTURE

Pretty Boxes

RF Catheter

Endovenous Laser Treatment

Mechanical Chemical Tumescentless Clarivein Uses combination of mechanical and chemical injury Still requires a fairly straight vein No risk of burn so superficial veins are okay

Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins van Eekeren RR1, Boersma D, Konijn V, de Vries JP, Reijnen MM. J Vasc Surg. 2013 Feb;57(2):445-50 Patients treated with MOCA reported significantly less postoperative pain than patients treated with RFA during the first 14 days after treatment (4.8 ± 9.7 mm vs 18.6 ± 17.0 mm; P <.001) significantly earlier return to normal activities (1.2 ± 1.8 vs 2.4 ± 2.8 days; P =.02) work resumption (3.3 ± 4.7 vs 5.6 ± 5.8 days, respectively; P =.02).

Chemical Ablation Sclerotherapy Physician compounded foam Polidocanol Microfoam (Varithena ) Cyanoacrylate (VenaSeal ) Tumescentless

Physician Compounded Foam

US Guided Sclerotherapy

Liquid I inject; high concentration low volume

Cerebral Vascular Incidents J Vasc Surg. 2006 Jan;43(1):162-4 Forlee MV, Grouden M, Moore DJ, Shanik G : Stroke after varicose vein foam injection sclerotherapy Phlebology. 2008;23(4):189-92. Bush RG, Derrick M, Manjoney D.: Report describes two complications of severe neurologic alterations (TIA, CVA) after foamed sclerotherapy injection Eur J Vasc Endovasc Surg. 2009 Nov;38(5):648-9. Epub 2009 Aug 14 Hartmann K, Harms L, Simon M : Reversible neurological deficit after foam sclerotherapy Ceulen RPM. Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008;358:1525-1526 2% incidence of serious neurologic complications

Polidocanol Microfoam Varithena FDA approval 2014 Superficial veins Tortuous veins Approved for GSV, Accessory veins Superficial varicosities Not the SSV

Cyanoacrylate Just got FDA approval Superglue Venaseal Delivered through a catheter so fairly straight veins Questionable for superficial veins

Perforator veins Usually not acting alone Deep and/or superficial disease usually present Treat with ligation, sclerotherapy, or thermal

RF Ablation of Incompetent Perforators Low morbidity Can perform through ulcer Results: 1 770 IP s in 506 limbs 79% closed at 1year 76% remained closed at 2 years Image courtesy of Paul McNeill, MD 1. E. Peden, A. Lumsden, Radiofrequency Ablation of Incompetent Perforator Veins. Perspect Vasc Surg Endovas Ther. 2007; 19; 73-77.

Pelvic Veins If for leg symptoms just treat the leg portion Treat from above for pelvic symptoms

Deep vein reflux Think obstruction Valve reconstruction has high morbidity Percutaneous valve replacement in the works

Marston W, Fish D, et al Incidence of and risk factor for iliocaval venous obstruction in patients with active or healed venous leg ulcers J Vasc Surg May 2011;53:5 1303-08

78 patients with ceap 5/6 37% had ICVO >50% 23% had ICVO >80% Risk factors for ICVO >80% were female, h/o DVT and DVR Duplex with absent respiratory phasicity 100% specificity and PPV (only 77% sensitive) No patients with superficial reflux alone was found to have ICVO>80%

Iliac Vein Duplex Ultrasound

MR Venography NIVL lesions present in silent form in 30-50% of the general population Courtesy Barry Stein, MD

IVUS, IVUS, IVUS

IVUS Phased array transducer Mechanical transducer

Contrast venography: oblique views Require more ionizing radiation Require more nephrotoxic contrast

Conclusion Lots of treatment options and more coming Most done in office and some in the vascular lab Minimal morbidity and minimal downtime